John J Sim1, Mark P Rutkowski2, David C Selevan2, Michael Batech3, Royann Timmins2, Jeff M Slezak3, Steven J Jacobsen3, Michael H Kanter2. 1. Division of Nephrology and Hypertension, Kaiser Permanente Los Angeles Medical Center, Los Angeles, Calif. Electronic address: John.j.sim@kp.org. 2. Regional Quality and Clinical Analysis, Southern California Permanente Medical Group, Kaiser Permanente Southern California, Pasadena. 3. Department of Research and Evaluation, Kaiser Permanente Southern California, Pasadena.
Abstract
BACKGROUND: Chronic kidney disease is highly prevalent but is challenging to diagnose because of the need to establish chronicity. Within the current healthcare environment, a single abnormal creatinine measurement often can go without a follow-up, which can lead to missed diagnoses or diagnostic errors. The Kaiser Permanente Southern California creatinine safety program (the Creatinine SureNet) was created to help ensure that all single abnormal creatinine results had a follow-up evaluation. METHODS: In the period February 1, 2010, to March 1, 2014, the electronic health records were used to capture individuals with single abnormal creatinine results that went >90 days without a repeat measurement. A coordinated effort among a centralized regional nurse and providers was used to communicate with patients and order a repeat creatinine measurement. RESULTS: A total of 12,396 individuals were identified (84% ambulatory care encounters). A total of 6981 individuals (52%) followed up with a repeat measurement. Female patients, non-Hispanic whites, and older individuals were more likely to obtain a repeat measurement. Subsequently, 3668 individuals had chronic kidney disease confirmed. Within 6 months, 1550 patients had chart documentation of their chronic kidney disease and 336 patients had a nephrology consultation. CONCLUSIONS: The ambulatory care environment, given its high volume and various prioritizations, is an under-recognized area where diagnostic errors are not uncommon and failure to follow up on abnormal test results can occur routinely. The Kaiser Permanente Southern California Creatinine SureNet program leverages the electronic health records and its multidisciplinary resources in an effort to ensure that patients with potential chronic kidney disease are identified and managed properly.
BACKGROUND:Chronic kidney disease is highly prevalent but is challenging to diagnose because of the need to establish chronicity. Within the current healthcare environment, a single abnormal creatinine measurement often can go without a follow-up, which can lead to missed diagnoses or diagnostic errors. The Kaiser Permanente Southern California creatinine safety program (the Creatinine SureNet) was created to help ensure that all single abnormal creatinine results had a follow-up evaluation. METHODS: In the period February 1, 2010, to March 1, 2014, the electronic health records were used to capture individuals with single abnormal creatinine results that went >90 days without a repeat measurement. A coordinated effort among a centralized regional nurse and providers was used to communicate with patients and order a repeat creatinine measurement. RESULTS: A total of 12,396 individuals were identified (84% ambulatory care encounters). A total of 6981 individuals (52%) followed up with a repeat measurement. Female patients, non-Hispanic whites, and older individuals were more likely to obtain a repeat measurement. Subsequently, 3668 individuals had chronic kidney disease confirmed. Within 6 months, 1550 patients had chart documentation of their chronic kidney disease and 336 patients had a nephrology consultation. CONCLUSIONS: The ambulatory care environment, given its high volume and various prioritizations, is an under-recognized area where diagnostic errors are not uncommon and failure to follow up on abnormal test results can occur routinely. The Kaiser Permanente Southern California Creatinine SureNet program leverages the electronic health records and its multidisciplinary resources in an effort to ensure that patients with potential chronic kidney disease are identified and managed properly.
Authors: Amy Z Sun; Yu-Hsiang Shu; Teresa N Harrison; Aviv Hever; Steven J Jacobsen; Michelle M O'Shaughnessy; John J Sim Journal: Perm J Date: 2020-02-07
Authors: Karly A Murphy; Raquel C Greer; Debra L Roter; Deidra C Crews; Patti L Ephraim; Kathryn A Carson; Lisa A Cooper; Michael C Albert; L Ebony Boulware Journal: J Gen Intern Med Date: 2019-11-12 Impact factor: 5.128
Authors: Ira M Lubin; J Rex Astles; Shahram Shahangian; Bereneice Madison; Ritchard Parry; Robert L Schmidt; Matthew L Rubinstein Journal: Diagnosis (Berl) Date: 2021-01-06
Authors: Robert L Schmidt; Joely A Straseski; Kalani L Raphael; Austin H Adams; Christopher M Lehman Journal: PLoS One Date: 2015-11-24 Impact factor: 3.240
Authors: Jason Oke; Brian Shine; Emily McFadden; Richard Stevens; Daniel Lasserson; Rafael Perera Journal: BMJ Open Date: 2015-12-16 Impact factor: 2.692